NEW YORK, Aug. 5, 2014 (GLOBE NEWSWIRE) -- Rosen Law Firm reminds purchasers of Regado Biosciences (Nasdaq:RGDO) securities from the date of the August 21, 2013 initial public offering ("IPO") through July 2, 2014, of the important September 8, 2014 lead plaintiff deadline in the class action.
To join the Regado class action, go to the website at http://www.rosenlegal.com/cases-register-305.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email firstname.lastname@example.org or email@example.com for information on the class action. The case is pending in the U.S. District Court for the District of New Jersey.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
According to the lawsuit, defendants made inaccurate statements of material fact or failed to disclose in its IPO documents: (1) the administration of Revolixys presented a significant risk of severe allergic reaction, which substantially undermined Revolixys' potential to become the new standard of care for anticoagulation therapy for patients undergoing cardiovascular procedures such as percutaneous coronary intervention ("PCI") to open or widen obstructed coronary arteries; and (2) the Company's positive statements about Revolixys' clinical development and potential to become the standard of care for anticoagulation therapy for patients undergoing PCI and other cardiovascular procedures were materially false and misleading or lacked a reasonable basis. When this adverse information entered the market, the price of Regado shares dropped, damaging investors.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 8, 2014. If you wish to join the litigation visit the website http://www.rosenlegal.com/cases-register-305.html. To discuss your rights or interests regarding this class action, please contact, Phillip Kim, Esq. or Kevin Chan, Esq. of The Rosen Law Firm toll free at 866-767-3653 or via e-mail at firstname.lastname@example.org or email@example.com.
The Rosen Law Firm focuses on prosecuting securities class action litigation and actions involving financial fraud. The Rosen Law Firm represents investors throughout the globe.
CONTACT: Laurence Rosen, Esq. Phillip Kim, Esq. Kevin Chan, Esq. The Rosen Law Firm P.A. 275 Madison Avenue 34th Floor New York, New York 10016 Tel: (212) 686-1060 Toll Free: 1-866-767-3653 Fax: (212) 202-3827 firstname.lastname@example.org email@example.com firstname.lastname@example.org www.rosenlegal.comSource: The Rosen Law Firm PA PC